MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2

FEBS Letters

Volumn 588, Issue 17, 2014, Pages 3055-3061

  Mei, Zhoufang ^a   He, Yanchao ^a   Feng, Jingjing ^a   Shi, Jindong ^a   Du, Yong ^a   Qian, Ling ^a   Huang, Qihui ^a   Jie, Zhijun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

MicroRNA 141; Non small cell lung cancer; PH domain leucine rich repeats protein phosphatase 1; PH domain leucine rich repeats protein phosphatase 2; Proliferation

Indexed keywords

MICRORNA 141; PH DOMAIN LEUCINE RICH REPEATS PROTEIN PHOSPHATASE 1; PH DOMAIN LEUCINE RICH REPEATS PROTEIN PHOSPHATASE 2; PHOSPHOPROTEIN PHOSPHATASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; NONHUMAN; PHLPP1 GENE; PHLPP2 GENE; PRIORITY JOURNAL; UPREGULATION;

MICRORNA-141; NON-SMALL CELL LUNG CANCER; PH DOMAIN LEUCINE-RICH-REPEATS PROTEIN PHOSPHATASE 1; PH DOMAIN LEUCINE-RICH-REPEATS PROTEIN PHOSPHATASE 2; PROLIFERATION;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICRORNAS; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; UP-REGULATION;

EID: 84906283166     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.06.020     Document Type: Article

References (29)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N. Engl. J. Med. 350 2004 379 392
3. J. Cai, L. Fang, Y. Huang, R. Li, J. Yuan, Y. Yang, X. Zhu, B. Chen, J. Wu, and M. Li MiR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer Cancer Res. 73 2013 5402 5415
4. Y. Zhou, L. Tian, X. Wang, L. Ye, G. Zhao, M. Yu, G. Li, Y. Lei, and Y. Huang MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB Cancer Lett. 347 2014 65 74
5. W.T. Liao, T.T. Li, Z.G. Wang, S.Y. Wang, M.R. He, Y.P. Ye, L. Qi, Y.M. Cui, P. Wu, H.L. Jiao, C. Zhang, Y.J. Xie, J.X. Wang, and Y.Q. Ding MicroRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2 Clin. Cancer Res. 19 2013 4662 4672
6. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
7. R. Garzon, G.A. Calin, and C.M. Croce MicroRNAs in cancer Annu. Rev. Med. 60 2009 167 179
8. J. Yao, L. Liang, S. Huang, J. Ding, N. Tan, Y. Zhao, M. Yan, C. Ge, Z. Zhang, T. Chen, D. Wan, M. Yao, J. Li, J. Gu, and X. He MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma Hepatology 51 2010 846 856
9. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.G. Liu, H. Alder, G.A. Calin, S. Ménard, and C.M. Croce MicroRNA signatures in human ovarian cancer Cancer Res. 67 2007 8699 8707
10. Y. Liu, Y. Ding, J. Huang, S. Wang, W. Ni, J. Guan, Q. Li, Y. Zhang, Y. Ding, B. Chen, and L. Chen MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1 PLoS One 9 2014 e88393
11. K.P. Porkka, M.J. Pfeiffer, K.K. Waltering, R.L. Vessella, T.L. Tammela, and T. Visakorpi MicroRNA expression profiling in prostate cancer Cancer Res. 67 2007 6130 6135
12. M. Zhang, S. Zhou, L. Zhang, J. Zhang, H. Cai, J. Zhu, C. Huang, and J. Wang MiR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma FEBS Lett. 586 2012 3508 3521
13. H.Y. Wan, L.M. Guo, T. Liu, M. Liu, X. Li, and H. Tang Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma Mol. Cancer 9 2010 16
14. T. Gao, F. Furnari, and A.C. Newton PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth Mol. Cell 18 2005 13 24
15. J. Brognard, E. Sierecki, T. Gao, and A.C. Newton PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms Mol. Cell 25 2007 917 931
16. A.C. Newton, and L.C. Trotman Turning off AKT: PHLPP as a drug target Annu. Rev. Pharmacol. Toxicol. 54 2014 537 558
17. R.I. Gregory, and R. Shiekhattar MicroRNA biogenesis and cancer Cancer Res. 65 2005 3509 3512
18. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, and T.R. Golub MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
19. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 2006 857 866
20. J.F. Wiggins, L. Ruffino, K. Kelnar, M. Omotola, L. Patrawala, D. Brown, and A.G. Bader Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 Cancer Res. 70 2010 5923 5930
21. Z. Hu, J. Chen, T. Tian, X. Zhou, H. Gu, L. Xu, Y. Zeng, R. Miao, G. Jin, H. Ma, Y. Chen, and H. Shen Genetic variants of miRNA sequences and non-small cell lung cancer survival J. Clin. Invest. 118 2008 2600 2608
22. A. Bendoraite, E.C. Knouf, K.S. Garg, R.K. Parkin, E.M. Kroh, K.C. O'Briant, A.P. Ventura, A.K. Godwin, B.Y. Karlan, C.W. Drescher, N. Urban, B.S. Knudsen, and M. Tewari Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition Gynecol. Oncol. 116 2010 117 125
23. Z.M. Zhu, Y.F. Xu, Q.J. Su, J.D. Du, X.L. Tan, Y.L. Tu, J.W. Tan, and H.B. Jiao Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma Mol. Cell. Biochem. 388 2014 39 49
24. X. Chen, X. Wang, A. Ruan, W. Han, Y. Zhao, X. Lu, P. Xiao, H. Shi, R. Wang, L. Chen, S. Chen, Q. Du, H. Yang, and X. Zhang MiR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression Clin Cancer Res 2014 [Epub ahead of print]
25. X.G. Liu, W.Y. Zhu, Y.Y. Huang, L.N. Ma, S.Q. Zhou, Y.K. Wang, F. Zeng, J.H. Zhou, and Y.K. Zhang High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer Med. Oncol. 29 2012 618 626
26. A.K. O'Neill, M.J. Niederst, and A.C. Newton Suppression of survival signalling pathways by the phosphatase PHLPP FEBS J. 280 2013 572 583
27. J.A. Fresno Vara, E. Casado, J. de Castro, P. Cejas, C. Belda-Iniesta, and M. González-Barón PI3K/Akt signalling pathway and cancer Cancer Treat. Rev. 30 2004 193 204
28. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
29. M. Saji, and M.D. Ringel The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors Mol. Cell. Endocrinol. 321 2010 20 28